Identification of aleutian mink disease parvovirus capsid sequences mediating antibody-dependent enhancement of infection, virus neutralization, and immune complex formation

Journal of Virology

Volumn 75, Issue 22, 2001, Pages 11116-11127

  Bloom, M E ^a   Best, S M ^a   Hayes, S F ^a   Wells, R D ^a   Wolfinbarger, J B ^a   McKenna, R ^a   Agbandje Mckenna, M ^a  

^a Division of Intramural Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CAPSID PROTEIN; FC RECEPTOR; PEPTIDE; POLYCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS VACCINE;

ALEUTIAN MINK DISEASE; AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; HYPERGAMMAGLOBULINEMIA; IMMUNE COMPLEX DISEASE; KIDNEY CELL; MACROPHAGE; NONHUMAN; PARVOVIRUS; PATHOGENESIS; PERSISTENT INFECTION; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS MORPHOLOGY; VIRUS NEUTRALIZATION; VIRUS PARTICLE;

ALEUTIAN MINK DISEASE; ALEUTIAN MINK DISEASE VIRUS; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; ANTIGEN-ANTIBODY COMPLEX; CAPSID; CATS; CELL LINE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOBLOTTING; MICROSCOPY, IMMUNOELECTRON; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS; SPODOPTERA;

EID: 0034765428     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.22.11116-11127.2001     Document Type: Article

References (64)

1. Vaccination with Aleutian mink disease parvovirus (AMDV) capsid proteins enhances disease, while vaccination with the major non-structural AMDV protein causes partial protection from disease
2. Treatment of neonatally Aleutian disease virus (ADV) infected mink with gammaglobulin containing antibodies to ADV reduces the death rate of mink kits
3. Aleutian disease virus, a parvovirus, is proteolytically degraded during in vivo infection in mink
4. Analysis of the quantity of antiviral antibodies from mink infected with different Aleutian disease virus strains
5. Functional implications of the structure of the murine parvovirus minute virus of mice
6. The recognition of parvovirus capsids by antibodies
7. The structure of parvoviruses
8. Detailed transcription map of Aleutian mink disease parvovirus
9. In situ molecular hybridization for detection of Aleutian mink disease parvovirus DNA by using strand-specific probes: Identification of target cells for viral replication in cell cultures and in mink kits with virus-induced interstitial pneumonia
10. Passive transfer of antiviral antibodies restricts replication of Aleutian mink disease parvovirus in vivo
11. Pathogenesis of Aleutian mink disease parvovirus infection: Effects of suppression of antibody response on viral mRNA levels and on development of acute disease
12. Mutations adjacent to the dimple of the canine parvovirus capsid structure affect sialic acid binding
13. Molecular tectonic model of virus structural transitions: The putative cell entry states of poliovirus
14. Construction of pathogenic molecular clones of Aleutian mink disease parvovirus that replicate both in vivo and in vitro
15. Aleutian mink disease: Puzzles and paradigms
16. Expression of Aleutian mink disease parvovirus capsid proteins in defined segments: Localization of immunoreactive sites and neutralizing epitopes to specific regions
17. Aleutian disease of mink: The antibody response of sapphire and pastel mink to Aleutian disease virus
18. Characterization of Aleutian disease virus as a parvovirus
19. Mapping the surface properties of macromolecules
20. Structure, sequence and function correlates among parvoviruses
21. Antibody-mediated neutralization of human rhinovirus 14 explored by means of cryoelectron microscopy and X-ray crystallography of virus-Fab complexes
22. Production of mink enteritis parvovirus empty capsids by expression in a baculovirus vector system: A recombinant vaccine for mink enteritis parvovirus in mink
23. Expression of Aleutian mink disease parvovirus proteins in a baculovirus vector system
24. Expression of Aleutian mink disease parvovirus capsid proteins by a recombinant vaccinia virus: Self-assembly of capsid proteins into particles
25. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: Its deletion leads to a strong neutralizing response
26. 2 with particular emphasis on Syrian hamsters
27. Epitope mapping of Aleutian mink disease parvovirus virion protein VPI and VP2
28. Aleutian mink disease parvovirus infection of K562 cells is antibody-dependent and is mediated via an Fc(gamma)RII receptor
29. Aleutian disease of mink: Properties of the etiologic agent and the host responses
30. Replication of Aleutian mink disease parvovirus in vivo is influenced by residues in the VP2 protein
31. Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope
32. Comparative pathogenicity of four strains of Aleutian disease virus for pastel and sapphire mink
33. Identification of Aleutian mink disease parvovirus transcripts in macrophages of infected adult mink
34. Aleutian mink disease parvovirus infection of mink macrophages and human macrophage cell line U937: Demonstration of antibody-dependent enhancement of infection
35. Aleutian mink disease parvovirus infection of mink peritoneal macrophages and human macrophage cell lines
36. Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor
37. B-cell epitopes of canine parvovirus: Distribution on the primary structure and exposure on the viral surface
38. Full protection in mink against mink enteritis virus with new generation canine parvovirus vaccines based on synthetic peptide or recombinant protein
39. Fine mapping of canine parvovirus B cell epitopes
40. The three-dimensional structure of Aleutian mink disease parvovirus: Implications for disease pathogenicity
41. Replication of Aleutian mink disease parvovirus in lymphoid tissues of adult mink: Involvement of follicular dendritic cells and macrophages
42. The relationship between capsid protein (VP2) sequence and pathogenicity of Aleutian mink disease parvovirus (ADV): A possible role for raccoons in the transmission of ADV infections
43. Subcellular localization of Aleutian mink disease parvovirus proteins and DNA during permissive infection of Crandell feline kidney cells
44. Structure of an antibody-antigen complex: Crystal structure of the HyHEL-10 Fab-lysozyme complex
45. Pathogenesis of feline panleukopenia and canine parvovirus
46. Antigenic relationships between canine parvovirus type 2, feline panleukopenia virus, and mink enteritis virus using conventional antisera and monoclonal antibodies
47. Comparisons of feline panleukopenia virus, canine parvovirus, raccoon parvovirus, and mink enteritis virus and their pathogenicity for mink and ferrets
48. Aleutian disease: A persistent parvovirus infection of mink with a maximal but ineffective host immune response
49. Aleutian disease of mink: Infectious virus-antibody complexes in the serum
50. The pathogenesis of Aleutian disease of mink J. In vivo viral replication and the host antibody response to viral antigen
51. The pathogenesis of Aleutian disease of mink II. Enhancement of tissue lesions following the administration of a killed virus vaccine or passive antibody
52. The pathogenesis of Aleutian disease of mink III. Immune complex arteritis
53. Monoclonal antibodies against Aleutian disease virus distinguish virus strains and differentiate sites of virus replication from sites of viral antigen sequestration
54. Picornaviruses: Epitopes, canyons, and pockets
55. Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon
56. Structure of a human rhinovirus-bivalently bound antibody complex: Implications for viral neutralization and antibody flexibility
57. Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody
58. Apparent lack of neutralizing antibodies in Aleutian disease is due to masking of antigenic sites by phospholipids
59. Two dominant neutralizing antigenic determinants of canine parvovirus are found on the threefold spike of the virus capsid
60. The three-dimensional structure of canine parvovirus and its functional implications
61. The structure of a neutralized virus: Canine parvovirus complexed with neutralizing antibody fragment Structure
62. Expression of Aleutian mink disease parvovirus capsid proteins in a baculovirus expression system for potential diagnostic use
63. Recombinant adeno associated virus purification using novel methods improves infectious titer and yield